Researchers surprised by similar structures in Sanfilippo syndrome and Alzheimer's disease

May 04, 2009
Stanislav Karsten, Ph.D., is an LA BioMed investigator and corresponding author of the study. Credit: Dana Maione

Researchers seeking to understand the causes of a rare genetic lysosomal storage disease, Sanfilippo syndrome type B, were surprised to find protein aggregates, known as neurofibrillary tangles, that are usually seen in Alzheimer's and other forms of dementia, according to a study published May 4 in the Proceedings of the National Academy of Sciences.

The discovery, in a study conducted at the Los Angeles Biomedical Research Institute (LA BioMed) and the University of California, Los Angeles (UCLA), means that the childhood dementia often seen in lysosomal storage diseases may have mechanisms similar to those found in Alzheimer's disease and other age-related dementias, which are characterized by an abnormal accumulation of the protein, P-tau.

The scientists also said these findings mean those suffering from these rare disorders could one day benefit from the abundance of research underway for the growing numbers of Alzheimer's patients.

"We were trying to determine what in the cellular environment makes certain more vulnerable to neurodegeneration, and we were surprised to find the presence of a protein, P-tau, and the corresponding aggregates similar to neurofibrillary tangles we see in Alzheimer's patients," said Stanislav L. Karsten, PhD, a corresponding author of the study and a LA BioMed investigator. "With the increasing incidence of Alzheimer's disease, we expect to see new drugs developed to prevent these neurofibrillary tangles or dissolve them. Our findings suggest those treatments could also benefit patients with this rare , Sanfilippo syndrome."

Sanfilippo syndrome, also known as MPS III, occurs in approximately one in 70,000 births, causing profound mental retardation, behavior problems and, frequently, death before the age of 20. It is one of nearly 40 lysosomal storage diseases caused by the body's inability to produce enzymes that break down and recycle materials in cells. Without the enzymes, materials are stored in virtually every cell of the body, causing severe damage over time. There is no treatment for Sanfilippo syndrome.

Alzheimer's disease affects 2 million to 4 million Americans, and their ranks are expected to grow to as many as 14 million by the middle of the 21st century as the population ages.

Source: Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center

Explore further: REM sleep critical for young brain development; medication interferes

Related Stories

Fast-food linked to Alzheimer's: Swedish scientists

Nov 28, 2008

Mice that were fed a diet rich in fat, sugar and cholesterol for nine months developed a preliminary stage of the morbid irregularities that form in the brains of Alzheimer's patients. The study results, published in a doctoral ...

Recommended for you

Making waves with groundbreaking brain research

Jul 03, 2015

New research by Jason Gallivan and Randy Flanagan suggests that when deciding which of several possible actions to perform, the human brain plans multiple actions simultaneously prior to selecting one of ...

Long-term memories are maintained by prion-like proteins

Jul 02, 2015

Research from Eric Kandel's lab at Columbia University Medical Center (CUMC) has uncovered further evidence of a system in the brain that persistently maintains memories for long periods of time. And paradoxically, ...

Water to understand the brain

Jul 02, 2015

To observe the brain in action, scientists and physicians use imaging techniques, among which functional magnetic resonance imaging (fMRI) is the best known. These techniques are not based on direct observations ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.